Navigation Links
Gene variations explain drug dose required to control seizures

improve dosing decisions, he added. In particular, it may be clinically relevant to determine whether physicians can safely increase drug doses more rapidly for some patients. Such a trial might also allow physicians to identify patients who might safely take a smaller dose, thereby minimizing their risk for adverse side effects, he added.

The findings in epilepsy set the stage for scientists to evaluate other conditions in which gene-based diagnostics might help determine the optimum dosage of particular therapies for particular patients, Goldstein said.

"For most drugs we know a lot about how and where they act in the body," Goldstein said. "The current results support the idea that known drug targets, transporters and drug metabolizing enzymes are good starting points for understanding variation among patients in drug response."

In Parkinson's disease, for example, a pharmacogenetic test might assist physicians in prescribing the drug dose that will balance short-term control of tremors with long-term drug side effects that eventually render the disease untreatable, he said. Patients' genetic makeup might also influence the dose of chemotherapy needed to successfully fight a tumor, while minimizing often intolerable side effects.


'"/>

Source:Duke University Medical Center


Page: 1 2 3 4

Related biology news :

1. Researchers map of genetic variations implicated in disease
2. A new kind of mutation could explain numerous phenotypic variations in various species
3. Gene variations contribute to aggression and anger in women
4. Jumping gene helps explain immune systems abilities
5. Gene sequencing explains bioremediation bug
6. Variation in womens X chromosomes may explain differences among individuals, between sexes
7. Iron exporter revealed that may explain common human disorder
8. New book explains antibiotic resistance for a broad audience
9. Cats indifference towards sugar explained
10. Monkeypox mystery: New research may explain why 2003 outbreak in the US wasnt deadly
11. Scientist uses form to explain function of key building blocks of life
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gene variations explain drug dose required control seizures

(Date:5/16/2013)... at MIT may someday eliminate the need for ... their blood-sugar levels and inject themselves with insulin. ... levels in the body and respond by secreting ... function of pancreatic islet cells, which are destroyed ... type of system could ensure that blood-sugar levels ...
(Date:5/16/2013)... and athletes choose to wear the color red when ... Psychological Science , a journal of the Association ... do with their testosterone levels. , The new study, ... of Sunderland and colleagues, demonstrated that males who chose ... higher testosterone levels than other males who chose blue. ...
(Date:5/16/2013)... about 23 million years old give unprecedented insight ... one of the most species-rich groups among the ... Professor Bettina Reichenbacher from the Division of Paleontology ... Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in Munich / ... fossils which they assign to the group of ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3High-testosterone competitors more likely to choose red 2Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3
... Oxford, October 10, 2011 - Elsevier, the word-leading ... services, announces the Progress in Nuclear Energy and Education ... March, 2012. The conference, organized by Elsevier ... chaired by Professor Malcolm Joyce of Lancaster University, provides ...
... critical receptor that fuels the brain and without which sentient ... scientists as a promising new drug target for Alzheimer,s and ... is being published online Oct. 11 in Nature Communication ... been shown to be useful as a drug target," says ...
... National Science Foundation (NSF) has selected a team of ... the new Sustainable Cities - People, Infrastructures and the ... is leading the project, which includes 20 U.S. universities, ... grant aims to bring together scientists from all over ...
Cached Biology News:Elsevier organizes Progress in Nuclear Energy and Education Conference 2New drug target for Alzheimer's, stroke is discovered by University at Buffalo scientists 2National Science Foundation selects University of Colorado Denver team to study city sustainability 2
(Date:5/17/2013)... Rust removal is one of home maintenance's essential processes. Without ... To help rust contractors make it less expensive, My Cleaning ... it called Rusterizer. It announced that for this month, ... Cleaning Products explained that rust could damage items in two ... The first one, it said, happens when rust forms in ...
(Date:5/16/2013)... May 16, 2013 Oven Industries, Inc. ... controllers and temperature sensors since 1964. Expertly ... in industrial control system applications. As one ... includes a generic, control loop feedback system, which helps ... used to adjust a systematic process, using a control ...
(Date:5/16/2013)... 16, 2013  HealthSparq, a trusted provider of ... largest regional health plans, will debut a new ... (AHIP) Institute 2013 conference on June 13.  The ... how health insurance companies across the country are ... marketplace demands for increased healthcare transparency. ...
(Date:5/16/2013)... YORK , May 16, 2013 ... new market research report is available ... Competitor Analysis: Therapeutic ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ...   The new ...
Breaking Biology Technology:Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2New PID Temperature Controllers Announced by Oven Industries Inc. 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8
... Reportlinker.com announces that a new market research ... Future of White Biotechnology in ... White biotechnology (WB) industry, which ... in biotechnology, is one of the most ...
... (Nasdaq: TELK ) today announced the initiation of ... patients with Revlimid refractory or resistant, deletion 5q myelodysplastic syndrome ... intended to enroll up to 117 evaluable patients. It employs ... transfusion dependent with Low to Intermediate-1 Risk MDS. Telintra will ...
... YORK, June 7, 2011 DuPont (NYSE: ... told investors at the JPMorgan Diversified Industries Conference to ... process innovation, selective investment in attractive areas, broad-based growth, ... productivity.  Kullman also reaffirmed DuPont,s 2011 earnings per share ...
Cached Biology Technology:Reportlinker Adds Future of White Biotechnology in China 2Reportlinker Adds Future of White Biotechnology in China 3Reportlinker Adds Future of White Biotechnology in China 4Reportlinker Adds Future of White Biotechnology in China 5Telik Announces Initiation of a Phase 2 Clinical Trial of Telintra® (Ezatiostat HCl) in Patients With Revlimid® Refractory or Resistant Deletion 5q Myelodysplastic Syndrome 2Telik Announces Initiation of a Phase 2 Clinical Trial of Telintra® (Ezatiostat HCl) in Patients With Revlimid® Refractory or Resistant Deletion 5q Myelodysplastic Syndrome 3DuPont Chair & CEO: Delivering Innovative Solutions and Long-term Growth 2DuPont Chair & CEO: Delivering Innovative Solutions and Long-term Growth 3
... Anti-AP-2 α, clone 8G8/5 GenBank Accession ... made human AP-2alpha/gamma fusion protein corresponding to ... 278-450 of human AP-2γ Formulation: 0.1M Tris-glycine, ... before the addition of glycerol to 30% ...
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5...
MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul...
... a glycoprotein. distributed in colon and ... breast, lung and salivary gland tissues. ... MUC1 and MUC2. Epitope: Tandem ... Immunogen: MUC3 tandem repeat peptide ...
Biology Products: